Vitamin K antagonists (VKAs) remain essential in the management of patients with mechanical heart valves, rheumatic mitral stenosis, and selected cases of atrial fibrillation. Because therapeutic effectiveness depends on maintaining the international normalized ratio (INR) within a narrow target range, strategies that improve INR stability are critical to reducing the risks of thromboembolic and hemorrhagic complications. Traditional clinic-based monitoring is limited by infrequent testing and delayed dose adjustments, prompting growing interest in patient self-testing (PST) and patient self-management (PSM). This review assessed the impact of PST and PSM on anticoagulation quality and clinical outcomes in adults treated with VKAs. A targeted PubMed search (2015–2025) identified meta-analyses and randomized controlled trial evaluating INR self-monitoring. Three high-quality sources—a Cochrane review, a network meta-analysis, and a meta-analysis focused on telemedicine-supported PST—served as the primary evidence base. Across studies, both PST and PSM significantly increased time in therapeutic range (TTR), typically by 5–10 percentage points compared with standard care. PSM and telemedicine-assisted PST demonstrated the greatest improvements. Enhanced TTR translated into reductions in thromboembolic events, particularly in high-intensity PSM strategies. Importantly, no increase in major bleeding was observed in any self-monitoring model, indicating a favorable safety profile. In conclusion, INR self-monitoring, especially intensive PSM and telemedicine-enabled PST, offers an effective and safe approach to improving anticoagulation control in patients requiring long-term VKA therapy. These strategies address well-recognized limitations of traditional INR monitoring and support more responsive, patient-centered care.
Background: Dental anxiety is a common phenomenon among children and frequently leads to avoidance of dental visits, reduced cooperation during procedures, and deterioration of oral health. A lack of cooperation poses significant challenges for clinicians, affecting the course, duration, and overall effectiveness of treatment. Early identification and appropriate management of anxiety and pain are therefore essential to ensure successful dental care and to promote positive oral health behaviors later in life.Aim of the study: The aim of this systematic review is to summarize the available methods for reducing anxiety and pain in pediatric dentistry.Material and methods: This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The review protocol was developed a priori and defined the research question, eligibility criteria, data sources, search strategy, record management procedures, and methods of data synthesis.Results: Over the years, numerous strategies have been developed in pediatric dentistry to address these concerns, including both non-pharmacological and pharmacological approaches. Behavioral and communicative techniques, as well as various distraction methods such as audiovisual aids, virtual reality, and music therapy, are widely used to support anxious children and improve their experience in the dental setting. Relaxation strategies and parental involvement further contribute to enhancing patient comfort and reducing procedural distress.When behavioral approaches are insufficient, sedation or general anesthesia may be employed to facilitate safe and effective treatment, ensuring that necessary procedures can be completed without compromising the quality of care. Recent advances also include the introduction of modern digital tools and child-friendly technologies designed to create a supportive and engaging dental environment.Conclusions: This review summarizes current methods for reducing anxiety and pain in children undergoing dental treatment and highlights emerging developments aimed at improving patient experience and overall clinical outcomes.
14 July 2026 in Journal of Education, Health and Sport
Introduction: Hypomagnesemia remains an underdiagnosed and undertreated condition, despite its profound adverse health effects. Recently, sodium-glucose cotransporter 2 inhibitors have emerged as effective agents in elevating serum magnesium levels. Aim of the Study: The aim of the study is a critical appraisal of the literature regarding the efficacy of sodium-glucose cotransporter 2 inhibitors in elevating serum magnesium levels in hypomagnesemic, non-diabetic patients. Methods and Materials: A literature search was conducted across major electronic databases for randomized controlled studies, post-hoc analyses of randomized controlled studies, observational studies and case reports evaluating the effects of sodium-glucose cotransporter 2 inhibitors on serum magnesium levels, with particular attention to the non-diabetic patient population. Seven articles met the eligibility criteria and formed the basis of this review. Results: Available data suggest that the use of SGLT2 inhibitors in non-diabetic patients with hypomagnesemia was consistently associated with increased serum magnesium levels. Patients with lower baseline magnesium concentrations appeared to experience more pronounced improvement of serum magnesium levels, which increased predominantly early in treatment before stabilizing at a plateau. In addition, treatment with SGLT2 inhibitors was frequently associated with a reduced need for magnesium supplementation. In the reviewed literature, data on safety and adverse effects were limited. The included studies had important methodological limitations, including small sample sizes and a predominantly retrospective observational design. Therefore, further well-designed prospective studies are required to confirm the observed effects and better characterize the safety profile of SGLT2 inhibitors in this population.
26 May 2026 in International Journal of Innovative Technologies in Social Science
Wolfram syndrome 1 is a rare autosomal recessive disorder caused by mutations in the WFS1 gene related to endoplasmic reticulum (ER) function. The course of the disease most often begins with diagnosis of insulin-dependent non-autoimmune diabetes mellitus with an early onset. Its clinical character is presented with an acronym DIDMOAD: diabetes insipidus (DI), diabetes mellitus (DM), optic atrophy (OA) and deafness (D). This article focuses on the clinical features of diabetes mellitus in Wolfram syndrome. We also describe current approach to its therapy and discuss possible treatment options placing the main emphasis on the GLP1 receptor agonists and cell regenerative therapy. Methods and materials: A qualitative synthesis of the data focusing on GLP-1 agonists, cell regenerative therapy and diabetes mellitus in Wolfram syndrome was performed. This literature review of GLP-1 receptor agonists and cell regenerative therapy effect on metabolic control, and current perspectives of treatment in patients with Wolfram syndrome, a monogenic type of diabetes, included recent publications, primarily from the past 10 years, and was conducted from November 2025 to April 2026 using the PubMed database. A systematic search was performed using specific keywords and medical subject headings (MeSH terms) related to GLP-1 agonists and Wolfram syndrome. The primary search terms included: “diabetes mellitus”, “GLP-1 agonists”, “Wolfram syndrome”, “WFS1”, “monogenic diabetes”, “islet transplantation”, and “cell regenerative therapy”. The criteria for inclusion of articles were as follows: published before April 2026, written in English, peer-reviewed original research articles. Exclusion criteria included publications not available in full text, articles in languages other than English. Editorials, commentaries, and conference abstracts without full data were also excluded. Titles and abstracts of the retrieved articles were screened to determine eligibility based on the inclusion and exclusion criteria.
2 July 2026 in International Journal of Innovative Technologies in Social Science
Intestinal malrotation is a congenital anomaly of the gastrointestinal tract that is most commonly diagnosed during the neonatal period. Delayed presentation beyond infancy is uncommon and may result in significant diagnostic challenges, particularly in children with complex genetic disorders. This case describes a 4-year-old girl with Edwards syndrome (Trisomy 18) whose atypical presentation of intestinal malrotation created a demanding clinical situation for the multidisciplinary healthcare team. The patient was admitted to the pediatric surgical department with coffee-ground vomiting and a one-week history of constipation. Due to severe developmental impairment and limited communication abilities associated with her genetic condition, the assessment of symptoms relied heavily on careful clinical observation. The nursing team played a crucial role in the diagnostic process through comprehensive assessment, including pain evaluation using the FLACC scale, continuous monitoring of vital signs, and detailed observation of the frequency and characteristics of emesis. These findings raised suspicion of a high-level intestinal obstruction and prompted further diagnostic investigations. Although the initial abdominal X-ray suggested a diaphragmatic hernia, surgical exploration revealed intestinal malrotation with volvulus consistent with Ladd’s syndrome. This case highlights the importance of advanced nursing assessment, clinical vigilance, and interdisciplinary collaboration in recognizing rare surgical emergencies and ensuring patient safety in children with significant communication barriers and complex healthcare needs.
6 November 2026 in International Journal of Innovative Technologies in Social Science
Obesity is a disease that is becoming increasingly common among children and is associated with a number of complications such as hypertension, the development of type 2 diabetes, non-alcoholic fatty liver disease and respiratory disorders. One of the methods of treating both obesity and its complications are surgical operations, e.g. bariatric surgery, among which surgical robots are increasingly used tools. Robotic surgery is similarly effective to standard techniques and is often associated with a shorter hospital stay for overweight children, making it an increasingly common procedure; however, its costs remain significant. This article focuses on the use of robotic surgery in the treatment of obesity and its complications in children. We also discuss the advantages and limitations of this type of procedure.